PAX3 and central nervous system cancer: The results from the CCK-8 assay unveiled a significant inhibition of cell proliferation of U251 (Figure 8A) and U87 cells (Figure 8B) upon PAX3 knockdown, while overexpression of PAX3 notably promoted glioma cell proliferation (Figures 8C, D).